REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.smaller Cos. Regulatory News (BSV)

Share Price Information for Br.smaller Cos. (BSV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 80.00
Bid: 78.50
Ask: 81.50
Change: 0.00 (0.00%)
Spread: 3.00 (3.822%)
Open: 80.00
High: 80.00
Low: 80.00
Prev. Close: 80.00
BSV Live PriceLast checked at -
British Smaller Companies VCT is an Investment Trust

To maximise Total Return and provide investors with an attractive long-term tax-free dividend yield while maintaining the Company's status as a venture capital trust.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

1st Quarter Results

13 Sep 2023 07:00

RNS Number : 2903M
British Smaller Companies VCT PLC
13 September 2023
 

British Smaller Companies VCT plc

Interim Management Statement

For the quarter ended 30 June 2023

British Smaller Companies VCT plc (the "Company") presents its interim management statement for the quarter ended 30 June 2023. The statement also includes relevant financial information between the end of the quarter and the date of this statement. A copy of this interim management statement can be found at www.bscfunds.com.

Overview

In the quarter to 30 June 2023, the Company's Net Asset Value per share return was unchanged at 83.7 pence. In comparison, the FTSE Small Cap Index fell by 0.4 per cent during the period. AIC data ranks the Company first across all generalist VCTs when considering a blended average performance ranking over 1, 3, 5, 7 and 10 years.

The Company's Total Return at 30 June 2023 was unchanged at 258.6 pence per ordinary share.

During the quarter, the Company invested £2.6 million into Workbuzz, an employee insights and engagement settlement platform. The Company also invested a further £0.8 million into Relative Insight.

The Company realised its investment in Ncam in April, generating initial proceeds of £1.4 million. There is the potential for additional receipts of up to £1.2 million depending on the achievement of certain milestones over the coming years, which would see the Company fully recover its investment; £0.3 million of deferred proceeds have been recognised at the period end.

Subsequent to the period end, the Company has made a further investment of £0.3 million into Elucidat.

Performance

The table below sets out movements in key metrics for the Company. 

 

 

31 March 2023

Increase in Value

Shares issued

Buyback of shares

Movement

In Period

30 June 2023

Net Assets (£m)

157.0

0.4

44.4

(0.4)

44.4

201.4

NAV per share (PPS)

83.7

0.2

(0.2)

-

-

83.7

Cumulative dividends paid (PPS)

174.9

-

-

-

-

174.9

Total Return (PPS)

258.6

0.2

(0.2)

-

-

258.6

Shares in issue

187,679,279

-

53,559,905

(451,965)

53,107,940

240,787,219

Cumulative dividends paid at 30 June 2023 were unchanged at 174.9 pence per ordinary share (31 March 2023: 174.9 pence per ordinary share).

The movements in NAV and NAV per ordinary share are set out in the table below:

 

 

£m

Pence per

ordinary share

NAV at 31 March 2023

157.0

83.7

Increase in portfolio value

0.6

0.3

Net operating costs

(0.2)

(0.1)

0.4

0.2

Issue/buy-back of shares*

44.0

(0.2)

Total Return in the period

44.4

-

NAV at 30 June 2023

 

201.4

 

83.7

 

* The allotment of shares from the 2022/23 fundraising reduced total return per ordinary share as the fundraising was priced at the last reported NAV at the time of the allotment of 82.8 pence per ordinary share, being the NAV as at 31 December 2022 of 87.3 pence per ordinary share, adjusted for the special interim dividend of 4.5 pence per ordinary share paid on 11 January 2023.

 

Post-period end, on 28 July 2023, a dividend of 2.0 pence per ordinary share for the year ending 31 March 2024 was paid, resulting in a corresponding reduction to the 30 June 2023 unaudited NAV, to 81.7 pence per ordinary share.

Dividends and shares in issue

On 4 April 2023, the Company allotted 53,559,905 shares following the close of its 2022/23 fundraising.

Under its standing buyback authority, on 26 June 2023 the Company purchased 451,965 shares at 80.02 pence at a cost of £0.36 million. These shares are held in treasury. 

Subsequent to the quarter end, on 28 July 2023 the Company issued 1,270,231 shares under the Company's Dividend Re-investment Scheme (DRIS) following the payment of the interim dividend, taking the number of shares in issue at that date to 242,057,450, with a further 22,459,730 shares held in treasury.

Net assets

Net assets at 30 June 2023 comprised the following:

£000

% of net assets

Unquoted investments at fair value

125,850

62.5

Listed investment funds

3,745

1.9

Cash and cash equivalents

69,854

34.7

Other net assets

1,993

0.9

Net assets

201,442

100.0

Investments

The investment portfolio at 30 June 2023 comprised:

Valuation

£000

Cumulative valuation as a % of net assets

Matillion

24,886

12.4%

Unbiased

10,511

17.6%

Displayplan

8,829

22.0%

Outpost

8,680

26.3%

Wooshii

6,981

29.7%

Elucidat

6,226

32.8%

Force24

4,758

35.2%

Vypr

4,159

37.2%

ACC Aviation

4,095

39.3%

Quality Clouds

4,032

41.3%

 

83,157

41.3%

Other investments

42,693

21.2%

Total investments

125,850

62.5%

Portfolio performance

Over the quarter to 30 June 2023, the aggregate unquoted portfolio valuation has increased by £0.8 million.

Fundraising

On 4 April 2023 the Company allotted shares from its fully subscribed 2022-23 share offer. £44.4 million was raised by the Company, resulting in the allotment of 53,559,905 ordinary shares.

On 2 August 2023, the Company announced its intention to launch a joint offer for subscription for the 2023-24 tax year later this year, alongside British Smaller Companies VCT2 plc. A prospectus with full details of the proposed Offer is expected to be published in mid-to-late September.

Outlook

Portfolio companies continue to show resilience in navigating a challenging macro environment, charting a path that balances continued growth with a move towards profitability. While rising interest rates will slow economic growth, a more capital constrained environment reduces competition and alternative funding sources, providing opportunities for further deployment of capital for the Company, in both new and existing portfolio companies. In this vein, the Company continues to see a healthy pipeline of opportunities in which to invest in fast growing British businesses.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

13 September 2023

For further information please contact:

David Hall YFM Private Equity Limited Tel: 0113 244 1000

Alex Collins Panmure Gordon (UK) Limited Tel: 0207 886 2767

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRFEALNDFAXDEEA
Date   Source Headline
26th Jun 20093:42 pmRNSAnnual Financial Report - Replacement
26th Jun 20092:23 pmRNSAnnual Financial Report Announcment
11th Feb 200911:33 amRNSIssue of Equity and Total Voting Rights
20th Jan 20099:50 amRNSInterim Management Statement
15th Jan 20094:09 pmRNSIssue of Equity and New Articles - Amendment
15th Jan 20091:46 pmRNSIssue of Equity and New Articles
16th Dec 20088:47 amRNSInterim Report and Circular to Shareholders
20th Nov 200811:00 amRNSHalf Year Financial Statements
1st Oct 20089:16 amRNSTransaction in Own Shares
8th Aug 20089:33 amRNSInterim Management Statement
7th Aug 20084:39 pmRNSAGM Statement
15th Jul 20084:08 pmRNSAnnual Report and Accounts
11th Jul 200811:31 amRNSPurchase of Own Shares and To
3rd Jul 20088:47 amRNSUnaudited Preliminary Results
1st Jul 20089:59 amRNSDirector Change
1st May 20083:48 pmRNSIssue of Equity
7th Apr 20083:53 pmRNSAllotment of shares and TVR
3rd Apr 20084:31 pmRNSCirc re. Fund Manager
1st Apr 200812:53 pmRNSPurchase of shares and TVR
29th Feb 200812:57 pmRNSDirectorate Change
20th Feb 20083:21 pmRNSPurchase of own shares & TVR
14th Feb 20083:25 pmRNSPurchase of shares and TVR
6th Feb 20084:32 pmRNSEGM Statement
24th Jan 20084:11 pmRNSInterim Management Statement
4th Jan 20084:04 pmRNSOffer for Subscription
30th Nov 20071:21 pmRNSPurchase of shares and TVR
17th Oct 200710:25 amRNSInterim Results
28th Sep 20074:56 pmRNSShare Buyback & Voting Rights
6th Sep 20079:37 amRNSAnnouncement re Cozart plc
5th Sep 20075:02 pmRNSSale of holding in Cozart plc
9th Aug 20079:53 amRNSInterim Management Statement
8th Aug 200712:47 pmRNSPurchase of Own Shares
1st Aug 20071:55 pmRNSIssue of Equity
29th Jun 20074:54 pmRNSTotal Voting Rights
29th Jun 20074:50 pmRNSTransaction in Own Shares
22nd Jun 200712:28 pmRNSTotal Voting Rights
12th Jun 20072:42 pmRNSFinal Results
16th May 20079:21 amRNSConversion of Securities
9th May 20073:48 pmRNSConversion of Securities
30th Apr 20075:08 pmRNSTotal Voting Rights
30th Apr 20075:06 pmRNSIssue of Equity
5th Apr 20074:30 pmRNSIssue of Equity
30th Mar 20079:33 amRNSTotal Voting Rights
22nd Mar 200711:28 amRNSTransaction in Own Shares
5th Mar 20071:04 pmRNSPurchase of Own Shares
31st Jan 20072:47 pmRNSTotal Voting Rights
31st Jan 200712:17 pmRNSPurchase of Own Shares
18th Jan 200710:46 amRNSNet Asset Value(s)
4th Jan 200711:42 amRNSEGM Statement
22nd Dec 200611:54 amRNSTransparency Directive

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.